Loss of sensation and trophic lesions in the feet of people with type 2 diabetes mellitus

Authors

DOI:

https://doi.org/10.56294/saludcyt2024617

Keywords:

Diabetic Foot, Diabetes Mellitus, Complications Of Diabetes, Semmes–Weinstein Monofilament, Wagner–Meggitt Classification

Abstract

Introduction: diabetic foot is one of the most common complications in patients with diabetes, and early diagnosis is crucial to carry out therapeutic interventions that prevent its progression to advanced or irreversible stages that generate changes in people's quality of life.
Objective: identify the loss of protective sensitivity and trophic lesions in the feet of people living with type 2 diabetes mellitus treated at a health center in the Tuxtlas region, Veracruz.
Methods: descriptive and cross-sectional study. The sampling was non-probabilistic for convenience in which 91 people participated. Information was collected on personal data, clinical data on podiatric characteristics, loss of foot protective sensitivity and presence of trophic lesions. Descriptive analysis was used in the SPSS statistical package.
Results: the average age was 52,59 years with a greater predominance in the group of 50 to 59 years. The foot disorders that occurred were calluses (65,9 %), onychomycosis (65,9 %) and pain (56 %). Regarding the quantification of trophic lesions, 13,2 % presented some degree of injury and 60,5 % presented loss of protective sensitivity in at least one of the six points evaluated in the lower limbs.
Conclusions: In the present study, a low prevalence of trophic lesions was identified according to the Wagner scale, but a high prevalence of neuropathy defined by monofilament; in addition, there are podiatric characteristics that can favor the presence of ulcers such as dermal and morphological alterations of the participants

References

1. Singh AK, Khunti K. COVID-19 and Diabetes. Annu Rev Med. 2022 Jan 27;73(1):129–47.

2. Basto-abreu A, López-olmedo N, Rojas-martínez R, et al. Prevalencia de prediabetes y diabetes en México: Ensanut 2022. Salud Publica Mex. 2023;65(1):4–9.

3. Eleftheriadou I, Tentolouris A, Grigoropoulou P, et al. The association of diabetic microvascular and macrovascular disease with cutaneous circulation in patients with type 2 diabetes mellitus. J Diabetes Complications. 2019;33(2):165–70.

4. Edmonds M, Manu C, Vas P. The current burden of diabetic foot disease. J Clin Orthop Trauma. 2021 Jun;17:88–93.

5. McIntosh C, Ivory JD, Gethin G, MacGilchrist C. Optimising Wellbeing in Patients with Diabetic Foot Ulcers. Journal of the European Wound Management Association. 2019 May 5;20(1):23–8.

6. Duarte JM, Bertotti AC, Puchulu F. Neuropatia precoz. Importancia de la Evaluacion Neurofisiologica en el sindrome metabolico con o sin disregulacion glucemica. Medicina (Buenos Aires). 2019;79:212–6.

7. Arellano Longinos SA, Godínez Tamay ED, Hernández Miranda MB. Prevalencia de neuropatía diabética en pacientes con diabetes mellitus tipo 2 en una clínica regional del Estado de México. Atención Familiar. 2017 Dec 14;25(1):7–11.

8. Kamei N, Yamane K, Nakanishi S, et al. Effectiveness of Semmes–Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabetes Complications. 2005 Jan;19(1):47–53.

9. Survival I. Evaluating Classification Systems of Diabetic Foot Ulcer Severity: A 12-Year Retrospective Study on Factors Impacting Survival. Healthcare. 2023;11.

10. Haryanto H, Makmuriana L, Hartono H, et al. Quality of life in patients with recurrent diabetic foot ulcers. Central European Journal of Nursing and Midwifery. 2023;14(1):833–8.

11. Shah P, Inturi R, Anne D, et al. Wagner’s Classification as a Tool for Treating Diabetic Foot Ulcers: Our Observations at a Suburban Teaching Hospital. Cureus. 2022 Jan 22;14(1):1–11.

12. Martínez-Escalante JE, Romero-Ibargüengoitia ME, Plata-Álvarez H, et al. Pie diabético en México: factores de riesgo para mortalidad posterior a una amputación mayor, a 5 años, en un hospital de salud pública de segundo nivel. Cir Cir. 2021 Feb 9;89(3):284–90.

13. Morgner MI, Djament L. Impact of Preventive and Mandatory Social Isolation in the control of type I diabetes in adults in the Buenos Aires Metropolitan Area. Community and Interculturality in Dialogue. 2023;3:82-82. https://doi.org/10.56294/cid202382.

14. Schimith MD, Silva SDO, Badke MR. Prevenção do pé diabético: práticas de cuidados de usuários de uma unidade saúde da família. 2021;1–7.

15. Botas Velasco M, Cervell Rodríguez D, Rodríguez Montalbán AI, et al. Actualización en el diagnóstico, tratamiento y prevención de la neuropatía diabética periférica. Angiologia. 2017;69:174–81.

16. Secretaría de Salud. Prevención, diagnóstico, tratamiento y rehabilitación del pie diabético. Guía de Práctica Clínica: Evidencias y Recomendaciones. México. 2020;301. http://www.cenetec-difusion.com/CMGPC/GPC-SS-005-20/ER.pdf

17. Delgado Díaz D, Herrera Villabona E, Camargo Lemos D. La prueba de los monofilamentos: una alternativa para la detección oportuna del riesgo de pie diabético. Rev Univ Ind Santander, Salud. 2004;36(1):32–9.

18. Kim Y, Kim H, Choi S, Park Y, Lee S, Cho B. Clinical Usefulness of the Two-site Semmes-Weinstein Monofilament Test for Detecting Diabetic Peripheral Neuropathy. J Korean Med Sci. 2003;18(1):103.

19. McComb WD. Wagner Grading of Diabetic Foot Ulcers and National Pressure Injury Advisory Panel Staging of Pressure Injuries: A Comparison for Clinical Use. Adv Skin Wound Care. 2023 May;36(5):278–9.

20. Shah P, Inturi R, Anne D, et al. Wagner’s Classification as a Tool for Treating Diabetic Foot Ulcers: Our Observations at a Suburban Teaching Hospital. Cureus. 2022 Jan 22;14(1):1–11.

21. Secretaría de Salud. Norma Oficial Mexicana NOM-015-SSA2 2010 Para la prevención, tratamiento y control de la Diabetes. Diario Oficial de la Federación. 2010.

22. Huang L-C, Lin C-L, Chang Y-T, Chen R-Y, Bai C-H. Gender Impact on Diabetes Distress Focus at Medical Communication Concerns, Life and Interpersonal Stress. Int J Environ Res Public Health. 2022 Nov 25;19(23):15678.

23. Zeyfang A, Wernecke J, Bahrmann A. Diabetes Mellitus at an Elderly Age. Experimental and Clinical Endocrinology & Diabetes. 2023 Feb 13;131(01/02):24–32.

24. Soriano EC, Lenhard MJ, Gonzalez JS, Tennen H, Otto AK, Perndorfer C, et al. Momentary Partner Involvement in Diabetes Self-Care and Continuously Measured Glucose: A Dynamic Analysis. Psychosom Med. 2022 Sep;84(7):808–12.

25. Al-Dwaikat TN, Rababah JA, Al-Hammouri MM, Chlebowy DO. Social Support, Self-Efficacy, and Psychological Wellbeing of Adults with Type 2 Diabetes. West J Nurs Res. 2021 Apr 16;43(4):288–97.

26. Lira Garibay M, Miguela López LR, Petro AV, et al. Reseña del 1o Congreso transdisciplinar de abordaje de heridas: “Avanzando hacia la Transdisciplinariedad en el manejo de las heridas crónicas”. Salud, Ciencia y Tecnología. 2022;2:148. https://doi.org/10.56294/saludcyt2022148

27. Pourkazemi A, Ghanbari A, Khojamli M, et al. Diabetic foot care: knowledge and practice. BMC Endocr Disord. 2020 Dec 20;20(1):40.

28. Basto-abreu A, López-olmedo N, Rojas-martínez R, et al. Prevalencia de prediabetes y diabetes en México: Ensanut 2022. Salud Publica Mex [Internet]. 2023;(1):4–9.

29. Gonzalez-Martin C, Pertega-Diaz S, Seoane-Pillado T, et al. Structural, dermal and ungual characteristics of the foot in patients with type II diabetes. Medicina (Lithuania). 2019;55(10):1–10.

30. Lauterbach S, Kostev K, Becker R. Characteristics of diabetic patients visiting a podiatry practice in Germany. J Wound Care. 2010 Apr 2;19(4):140–8.

31. Chuquitarco Marín PA, Chunchi Ayala LM, Gómez Guapizaca KP, Taimal Sárez CM. Perfil bacteriológico de las infecciones del pie diabético y su tratamiento antibiótico de elección. Salud, Ciencia y Tecnología. 2022 Dec 30;2(S1):215.

32. Hicks CW, Wang D, Windham BG, Matsushita K, Selvin E. Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Sci Rep. 2021 Sep 27;11(1):19159.

33. Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019 Jun 13;5(1):41.

34. Yıldırım Usta Y, Dikmen Y, Yorgun S, Berdo İ. Predictors of foot care behaviours in patients with diabetes in Turkey. PeerJ. 2019 Feb 8;7(2): e6416.

35. Brocco E, Ninkovic S, Marin M, et al. Diabetic foot management: multidisciplinary approach for advanced lesion rescue. J Cardiovasc Surg (Torino). 2018 Aug;59(5):670–84.

Downloads

Published

2024-01-01

How to Cite

1.
Pucheta-Xolo G, Tegoma-Ruiz VM, Sánchez-Hernández JR, Santiago-Mijangos AD, Chiu-Cruz YS. Loss of sensation and trophic lesions in the feet of people with type 2 diabetes mellitus. Salud, Ciencia y Tecnología [Internet]. 2024 Jan. 1 [cited 2024 Dec. 4];4:617. Available from: https://sct.ageditor.ar/index.php/sct/article/view/655